Deep Track Capital, LP: TARSUS PHARMACEUTICALS INC (TARS): Quarterly 13F Position History
As of Q1 2026, Deep Track Capital, LP reported 3,600,000 shares of TARSUS PHARMACEUTICALS INC (TARS), worth $252.5M and representing 5.2% of its 13F equity book. Quarter-over-quarter share count change: + 595,966 (+19.8%) . The position first appeared in Q1 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.
- 3,600,000Shares Held (Latest Filing)
- $252.5MReported Market Value (Latest Filing)
- 5.2%Portfolio Weight (% of 13F Equity Book)
- +595,966Quarter-over-Quarter Share Change
- +$6.6MQuarter-over-Quarter Value Change
- 3,600,000Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 3,600,000 | +595,966 | +19.8% | $252.5M | 5.2% | $70.2 |
| Q4 2025 | 3,004,034 | +4,034 | +0.1% | $246.0M | 5.6% | $81.9 |
| Q3 2025 | 3,000,000 | +1,250,000 | +71.4% | $178.3M | 5.0% | $59.4 |
| Q2 2025 | 1,750,000 | +265,734 | +17.9% | $70.9M | 2.3% | $40.5 |
| Q1 2025 | 1,484,266 | — | — | $76.2M | 2.5% | $51.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Deep Track Capital, LP first disclose a TARS position in 13F-HR filings?
Deep Track Capital, LP first reported TARSUS PHARMACEUTICALS INC (TARS) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Deep Track Capital, LP's most recent quarter-over-quarter share-count change in TARS?
Between Q4 2025 and Q1 2026, Deep Track Capital, LP added 595,966 shares of TARS (+19.8%), bringing the total reported position to 3,600,000 shares at a market value of $252.5M.
Does the implied price-per-share represent Deep Track Capital, LP's cost basis in TARS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.